CA
NZ
UK
AU
IND
US
XORTX Therapeutics (NASDAQ:XRTX), aPenny Stocktrading near $1.58, fell sharply in today's session even after the company outlined plans to file a Clinical Trial Application with Health Canada for XRx-026, its lead gout treatment program. The news appears to have disappointed investors who may have …
Humana (NYSE:HUM) gained 14.64% to USD 443.78 in the October 9, 2026 session, giving it aMarket Valuenear USD 53.29 billion, according to published market data. Published reports tie the move to the Medicare Advantage Star Ratings for 2027, which the Centers for Medicare and …
Humana (NYSE:HUM) gained 12.72%, or USD 49.24, to USD 436.36 in the October 9, 2026 session onVolumeof 2.502 million shares. Published reports tie the move to the 2027 Medicare Advantage Star Ratings, which the Centers for Medicare and Medicaid Services released on Thursday, October …
Moderna (NASDAQ:MRNA) rose 5.67% to USD 208.16 in the October 9, 2026 session, a gain of USD 11.16 from a prior close near USD 197.00, on about 13.0 million shares. No company release, filing or analyst action dated October 8 or 9 was found, …
Kardigan (NASDAQ:KARD) gained 9.33% to USD 15.53 in the October 9, 2026 session, a level that works out to about 2.9% below the USD 16 initial public offering price by this article's own arithmetic. No company release, filing or analyst action dated October 8 …
Moderna (NASDAQ:MRNA) rose 5.67% to USD 208.16 in the October 9, 2026 session, a gain of USD 11.16 from a prior close near USD 197.00 (simple arithmetic on two published numbers), on about 13.0 million shares. No company release, filing or analyst action dated …
Novavax (NASDAQ:NVAX) rose about 6.8% to USD 11.78 in the October 9, 2026 session, with market data labelling the move as news and lists aMarket Valuenear USD 1.94 billion. A search of company releases and published reports found no announcement dated October 8 or …
Mirum Pharmaceuticals (NASDAQ:MIRM) rose about 5.2% to USD 85.58 in the October 9, 2026 session, with no catalyst identified, and no company announcement was found for October 8 or 9. Published market data showed a close near USD 81.35 on October 8, which fits …
Humana (NYSE:HUM) gained 12.72%, or USD 49.24, to USD 436.36 in the October 9, 2026 session onVolumeof 2.502 million shares. Published reports tie the move to the 2027 Medicare Advantage Star Ratings, which the Centers for Medicare and Medicaid Services released on Thursday, October …
Novavax (NASDAQ:NVAX) rose 8.99%, or USD 0.99, to USD 12.00 in the October 9, 2026 session onVolumeof 7.623 million shares. A search of company releases and published reports found no announcement dated October 8 or October 9, so there is no company announcement found …
Please wait processing your request...